BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30350935)

  • 1. In Situ Detection of Plasma Exosomal MicroRNA-1246 for Breast Cancer Diagnostics by a Au Nanoflare Probe.
    Zhai LY; Li MX; Pan WL; Chen Y; Li MM; Pang JX; Zheng L; Chen JX; Duan WJ
    ACS Appl Mater Interfaces; 2018 Nov; 10(46):39478-39486. PubMed ID: 30350935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer plasma biopsy by in situ determination of exosomal microRNA-1246 with a molecular beacon.
    Chen Y; Zhai LY; Zhang LM; Ma XS; Liu Z; Li MM; Chen JX; Duan WJ
    Analyst; 2021 Apr; 146(7):2264-2276. PubMed ID: 33599630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermophoretic Detection of Exosomal microRNAs by Nanoflares.
    Zhao J; Liu C; Li Y; Ma Y; Deng J; Li L; Sun J
    J Am Chem Soc; 2020 Mar; 142(11):4996-5001. PubMed ID: 32134270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
    Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmoelectronic-Based Ultrasensitive Assay of Tumor Suppressor microRNAs Directly in Patient Plasma: Design of Highly Specific Early Cancer Diagnostic Technology.
    Liyanage T; Masterson AN; Oyem HH; Kaimakliotis H; Nguyen H; Sardar R
    Anal Chem; 2019 Feb; 91(3):1894-1903. PubMed ID: 30608133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and Specific Detection of Exosomal miRNAs for Accurate Diagnosis of Breast Cancer Using a Surface-Enhanced Raman Scattering Sensor Based on Plasmonic Head-Flocked Gold Nanopillars.
    Lee JU; Kim WH; Lee HS; Park KH; Sim SJ
    Small; 2019 Apr; 15(17):e1804968. PubMed ID: 30828996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer.
    Wang X; Qian T; Bao S; Zhao H; Chen H; Xing Z; Li Y; Zhang M; Meng X; Wang C; Wang J; Gao H; Liu J; Zhou M; Wang X
    Mol Oncol; 2021 Sep; 15(9):2466-2479. PubMed ID: 34058065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
    Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
    Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Detection and Analysis of Exosomes Using Surface-Enhanced Raman Scattering Gold Nanorods and a Miniaturized Device.
    Kwizera EA; O'Connor R; Vinduska V; Williams M; Butch ER; Snyder SE; Chen X; Huang X
    Theranostics; 2018; 8(10):2722-2738. PubMed ID: 29774071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative detection of exosomal microRNA extracted from human blood based on surface-enhanced Raman scattering.
    Ma D; Huang C; Zheng J; Tang J; Li J; Yang J; Yang R
    Biosens Bioelectron; 2018 Mar; 101():167-173. PubMed ID: 29073517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ single step detection of exosome microRNA using molecular beacon.
    Lee JH; Kim JA; Kwon MH; Kang JY; Rhee WJ
    Biomaterials; 2015 Jun; 54():116-25. PubMed ID: 25907045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
    Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
    Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ multiplex detection of serum exosomal microRNAs using an all-in-one biosensor for breast cancer diagnosis.
    Wang H; He D; Wan K; Sheng X; Cheng H; Huang J; Zhou X; He X; Wang K
    Analyst; 2020 May; 145(9):3289-3296. PubMed ID: 32255115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-in-one nanoflare biosensor combined with catalyzed hairpin assembly amplification for in situ and sensitive exosomal miRNA detection and cancer classification.
    Zhang XW; Du L; Liu MX; Wang JH; Chen S; Yu YL
    Talanta; 2024 Jan; 266(Pt 2):125145. PubMed ID: 37660618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An electrochemical nanobiosensor for plasma miRNA-155, based on graphene oxide and gold nanorod, for early detection of breast cancer.
    Azimzadeh M; Rahaie M; Nasirizadeh N; Ashtari K; Naderi-Manesh H
    Biosens Bioelectron; 2016 Mar; 77():99-106. PubMed ID: 26397420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanozyme-assisted sensitive profiling of exosomal proteins for rapid cancer diagnosis.
    Di H; Mi Z; Sun Y; Liu X; Liu X; Li A; Jiang Y; Gao H; Rong P; Liu D
    Theranostics; 2020; 10(20):9303-9314. PubMed ID: 32802193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients.
    Eichelser C; Stückrath I; Müller V; Milde-Langosch K; Wikman H; Pantel K; Schwarzenbach H
    Oncotarget; 2014 Oct; 5(20):9650-63. PubMed ID: 25333260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.